Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,792 papers from all fields of science
Search
Sign In
Create Free Account
Nonrenal Clearance
Known as:
NRENALCL
, Nonrenal CL
A measurement of the total clearance rate of a substance from the blood minus the renal clearance rate of that substance.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC SDTM Pharmacokinetic Parameter Long Name Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.
H. Agersø
,
Lotte Seiding Larsen
,
A. Riis
,
U. Lövgren
,
M. Karlsson
,
T. Senderovitz
British Journal of Clinical Pharmacology
2004
Corpus ID: 33918245
OBJECTIVE To evaluate the influence of renal impairment on the pharmacokinetics of desmopressin. METHODS Twenty-four subjects…
Expand
1996
1996
Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants
J. Sullivan
,
M. Witte
,
T. Yamashita
,
C. Myers
,
J. Blumer
Clinical pharmacology and therapy
1996
Corpus ID: 21337478
Highly Cited
1995
Highly Cited
1995
Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis patients.
Takashi Akiba
,
Noriaki Matsui
,
S. Shinohara
,
H. Fujiwara
,
Takeo Nomura
,
Fumiaki Marumo
Artificial Organs
1995
Corpus ID: 36845476
The effects of recombinant human erythropoietin (rHuEPO) and exercise training on exercise capacity were evaluated in 20…
Expand
1994
1994
Renal and Nonrenal Clearance of Clodronate in Patients with Malignancy and Renal Impairment
N. O'Rourke
,
E. McCloskey
,
G. Neugebauer
,
J. Kanis
1994
Corpus ID: 57734998
SummaryThe short term pharmacokinetics of the bisphosphonate clodronate were studied in 20 patients with tumour-mediated bone…
Expand
1990
1990
Nonlinear kinetics of the thiamine cation in humans: Saturation of nonrenal clearance and tubular reabsorption
W. Weber
,
M. Nitz
,
M. Looby
Journal of pharmacokinetics and biopharmaceutics
1990
Corpus ID: 24868715
The pharmacokinetics of thiamine in plasma and urine was investigated in 13 healthy and 3 renal-insufficient volunteers. Doses…
Expand
1988
1988
Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis
G. Alvan
,
B. Beermann
,
L. Hjelte
,
M. Lind
,
A. Lindholm
,
B. Strandvik
Clinical pharmacology and therapy
1988
Corpus ID: 19066056
The pharmacokinetics of furosemide and its diuretic effect were studied in six patients with cystic fibrosis (CF) and in six age…
Expand
1985
1985
Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis
Craig R Lehmann
,
James D. Heironimus
,
+5 authors
George J Wright
Clinical pharmacology and therapy
1985
Corpus ID: 33747096
Metoclopramide kinetics were examined in 24 adult patients with diminished renal function and in eight healthy subjects with…
Expand
Highly Cited
1981
Highly Cited
1981
Furosemide disposition in cirrhotic patients.
V. Sawhney
,
P. Gregory
,
S. Swezey
,
T. Blaschke
Gastroenterology
1981
Corpus ID: 28380434
Highly Cited
1981
Highly Cited
1981
Quinidine-digoxin interaction: time course and pharmacokinetics.
E. Leahey
,
J. Bigger
,
+4 authors
Jeffrey N. Rottman
American Journal of Cardiology
1981
Corpus ID: 11425395
1977
1977
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay
A. Broughton
,
J. Strong
,
P. Holoye
,
C. Bedrossian
Cancer
1977
Corpus ID: 22282465
The clinical pharmacology of bleomycin administered by continuous intravenous infusion over a 4 to 5 day period was examined in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE